MicroRNA dynamics, PTEN/PI3K/AKT signaling, and their relationship to breast cancer: prospects for pharmaceuticals and natural product application
Published in Cancer
Background
Globally, Breast Cancer (BC) is the most frequent cancer in women and has a major negative impact on the physical and emotional well-being of its patients as well as one of the most common cancers to be diagnosed. Numerous studies have been published to identify various molecular pathways, including PI3K/AKT/PTEN. Moreover, growing evidence suggests that miRNAs have been found to play a vital role in the growth and carcinogenesis of tumors. Because of their crucial in the development and course of the illness, all other molecular variables, molecular pathways and microRNAs have gained recognition as important therapeutic targets in BC due to growing interest among researchers in utilizing synthetic drugs and natural products to target these signaling pathway with encouraging outcomes in vivo, in vitro and preclinical trials in recent years.
Methods
We searched PUBMED, Science Direct, google scholar, Embase and Scopus for article published from the inception of each database to May 30, 2024.
Result
We discussed PI3K/PTEN/AKT signaling pathway and microRNA activities with breast cancer cell line. In addition, this review covered a wide range of potential drug and natural products as targeted therapies that are linked to downregulating ER-α expression and activity, inhibiting proliferation, migration, metastasis and angiogenesis, inducing apoptosis, cell cycle arrest and sensitizing breast cancer cells. Many studies have been conducted, but as of right now, there are not enough articles to fully explain the treatment and research of breast cancer.
Conclusion
We also need more and more studies on breast cancer from a variety of perspectives. Future scientist will find it easier to consider breast cancer treatment after reading this article presentation. So, the review focuses on our understanding of the roles that microRNA and PI3/PTEN/AKT signaling pathways play in regulating BC. Furthermore, we emphasized the potential therapeutic benefits of newly discovered inhibitors and the use of natural compounds in alone or combinations during preclinical trials.
I am interested in using Cancer and Molecular Biology and cellular response with molecular Mechanism to understand and model the biology of cancer and to develop methods to effectively deploy therapeutic agents in the age of molecularity guided medicine. Members of my lab or all of my coauthors use a combination of conventional molecular biology.
Follow the Topic
-
Breast Cancer Research and Treatment
This is an international arena for the discussion and resolution of ongoing controversies in breast cancer treatment, or for the consideration of thoughtful speculation and comments on current work.
Related Collections
With collections, you can get published faster and increase your visibility.
Cancer Disparities
In line with the UN Sustainable Development Goal to Reduce Inequalities (SDG10), this collection aims to bring together articles enhancing our understanding of cancer health disparities across the different dimensions of inequality research.
There are many expanding fields of health inequalities research but this collection will include articles examining disproportionate cancer burdens in populations such as: rural-urban, gender/sexual, racial/ethnic, religious minority and socioeconomic status groups, and of course any group where health inequality needs to be addressed.
This wider collection builds upon our existing collections more specifically focused on 'Racial and ethnic disparities in cancer' and 'Racial and ethnic disparities in cancer in the US'.
We are building an ongoing knowledge base of content from across oncology journals to increase the discoverability of articles in this important research area. Thus, we call for new contributions to this collection and invite you to read recent research below.
We also wish to highlight a related webinar recording 'Roundtable on Black in cancer research and oncology'.
Editors for Supportive Care in Cancer: Dr Devon Check and Prof Janet de Groot
Editors for Prostate Cancer and Prostatic Diseases: Dr Samuel L. Washington III, Dr Jun Luo, Dr Yaw Nyame, Dr Randy Vince Jr and Dr Jennifer Beebe-Dimmer
Please note that other journals participating in the collection do not have specific Guest Editors appointed and manuscripts are handled on a case by case basis by members of our editorial boards.
Publishing Model: Hybrid
Deadline: Ongoing
Liquid Biopsy in Breast Cancer
Publishing Model: Hybrid
Deadline: Ongoing
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in